Heart-rate reduction and beta-blockade in early post-infarction cardiac remodelling.
Goldstein
Robert E
RE
Haigney
Mark C P
MC
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology* / Q000627:therapeutic use; D000818:Animals; D002118:Calcium / Q000378:metabolism; D004195:Disease Models, Animal; D006339:Heart Rate / Q000187:drug effects* / Q000502:physiology; D017379:Hypertrophy, Left Ventricular / Q000473:pathology / Q000503:physiopathology / Q000517:prevention & control; D009203:Myocardial Infarction / Q000378:metabolism / Q000503:physiopathology*; D051381:Rats; D019831:Sodium-Calcium Exchanger / Q000378:metabolism; D020257:Ventricular Remodeling / Q000187:drug effects* / Q000502:physiology
D000319:Adrenergic beta-Antagonists; D019831:Sodium-Calcium Exchanger; D002118:Calcium